X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-3-2021-1635913559.pdf
https://www.globenewswire.com/news-release/2021/09/14/2296511/33090/en/Axsome-Therapeutics-Announces-FDA-Acceptance-of-New-Drug-Application-for-AXS-07-for-the-Acute-Treatment-of-Migraine.html
http://www.globenewswire.com/news-release/2020/09/24/2098506/0/en/Axsome-Therapeutics-Presents-New-Data-from-MOMENTUM-Phase-3-Trial-with-AXS-07-Demonstrating-Rapid-Onset-of-Action-and-Reduced-Symptom-Recurrence-in-the-Acute-Treatment-of-Migraine.html
https://www.globenewswire.com/news-release/2020/04/06/2011946/0/en/Axsome-Therapeutics-Announces-AXS-07-Achieves-Both-Co-Primary-Endpoints-and-Prevents-Migraine-Pain-Progression-in-the-INTERCEPT-Phase-3-Trial-in-the-Early-Treatment-of-Migraine.html
http://www.pharmatimes.com/news/late-stage_success_for_experimental_migraine_drug_1321225
https://www.globenewswire.com/news-release/2019/12/30/1964870/0/en/Axsome-Therapeutics-Announces-AXS-07-Achieves-Co-Primary-and-Key-Secondary-Endpoints-in-MOMENTUM-Phase-3-Migraine-Trial-in-Patients-with-History-of-Inadequate-Response.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207835
http://www.aninews.in/newsdetail-Mw/Mjk1ODM5/panacea-biotec-up-13-pct-on-us-fda-nod-for-migraine-drug.html
https://globenewswire.com/news-release/2016/12/14/897555/0/en/RedHill-Biopharma-and-IntelGenx-Announce-Definitive-Agreement-for-Commercialization-of-RIZAPORT-for-Migraines-with-Pharmatronic-Co-in-South-Korea.html
http://aux.cphi-online.com/uspto-granted-patent-protecting-intelgenx-s-news039164.html
https://www.pharmacompass.com/pdf/news/alkem-labs-ltds-generic-rizatriptan-benzoate-approved-in-us-to-treat-migraine-headaches-1456221684.pdf
Market Place
Share 
